These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37438825)

  • 1. Impact of seed amplification assay and surface-enhanced Raman spectroscopy combined approach on the clinical diagnosis of Alzheimer's disease.
    D'Andrea C; Cazzaniga FA; Bistaffa E; Barucci A; de Angelis M; Banchelli M; Farnesi E; Polykretis P; Marzi C; Indaco A; Tiraboschi P; Giaccone G; Matteini P; Moda F
    Transl Neurodegener; 2023 Jul; 12(1):35. PubMed ID: 37438825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raman spectroscopy and machine learning for biomedical applications: Alzheimer's disease diagnosis based on the analysis of cerebrospinal fluid.
    Ryzhikova E; Ralbovsky NM; Sikirzhytski V; Kazakov O; Halamkova L; Quinn J; Zimmerman EA; Lednev IK
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Mar; 248():119188. PubMed ID: 33268033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hollow core photonic crystal fiber-assisted Raman spectroscopy as a tool for the detection of Alzheimer's disease biomarkers.
    Eravuchira P; Banchelli M; D'Andrea C; De Angelis M; Matteini P; Gannot I
    J Biomed Opt; 2020 Jul; 25(7):1-10. PubMed ID: 32618152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Alzheimer's Disease Using Saliva: A New Approach Based on Machine Learning and Raman Hyperspectroscopy.
    Ralbovsky NM; Halámková L; Wall K; Anderson-Hanley C; Lednev IK
    J Alzheimers Dis; 2019; 71(4):1351-1359. PubMed ID: 31524171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An approach for in-situ detection of gold colloid aggregates amyloid formations within the hippocampus of the Cohen's Alzheimer's disease rat model by surface enhanced raman scattering methods.
    Yokoyama K; Thomas J; Ardner W; Kieft M; Neuwirth LS; Liu W
    J Neurosci Methods; 2023 Jun; 393():109892. PubMed ID: 37230258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust and Universal SERS Sensing Platform for Multiplexed Detection of Alzheimer's Disease Core Biomarkers Using PAapt-AuNPs Conjugates.
    Zhang X; Liu S; Song X; Wang H; Wang J; Wang Y; Huang J; Yu J
    ACS Sens; 2019 Aug; 4(8):2140-2149. PubMed ID: 31353891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser tweezers Raman spectroscopy combined with machine learning for diagnosis of Alzheimer's disease.
    Lin M; Ou H; Zhang P; Meng Y; Wang S; Chang J; Shen A; Hu J
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 280():121542. PubMed ID: 35792482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly sensitive surface-enhanced Raman scattering-based immunosensor incorporating half antibody-fragment for quantitative detection of Alzheimer's disease biomarker in blood.
    Yang SJ; Lee JU; Jeon MJ; Sim SJ
    Anal Chim Acta; 2022 Feb; 1195():339445. PubMed ID: 35090659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Biomarker Screening of Alzheimer's Disease by Interpretable Machine Learning and Graphene-Assisted Raman Spectroscopy.
    Wang Z; Ye J; Zhang K; Ding L; Granzier-Nakajima T; Ranasinghe JC; Xue Y; Sharma S; Biase I; Terrones M; Choi SH; Ran C; Tanzi RE; Huang SX; Zhang C; Huang S
    ACS Nano; 2022 Apr; 16(4):6426-6436. PubMed ID: 35333038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of misfolded Aβ oligomers for sensitive biochemical diagnosis of Alzheimer's disease.
    Salvadores N; Shahnawaz M; Scarpini E; Tagliavini F; Soto C
    Cell Rep; 2014 Apr; 7(1):261-8. PubMed ID: 24656814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Feasibility of Early Alzheimer's Disease Diagnosis Using a Neural Network Hybrid Platform.
    Yu X; Srivastava S; Huang S; Hayden EY; Teplow DB; Xie YH
    Biosensors (Basel); 2022 Sep; 12(9):. PubMed ID: 36140138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-functionalized SERS platform for deep learning-assisted diagnosis of Alzheimer's disease.
    Kim M; Huh S; Park HJ; Cho SH; Lee MY; Jo S; Jung YS
    Biosens Bioelectron; 2024 May; 251():116128. PubMed ID: 38367567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.
    Babić Leko M; Borovečki F; Dejanović N; Hof PR; Šimić G
    J Alzheimers Dis; 2016; 50(3):765-78. PubMed ID: 26836160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
    Massetti N; Russo M; Franciotti R; Nardini D; Mandolini GM; Granzotto A; Bomba M; Delli Pizzi S; Mosca A; Scherer R; Onofrj M; Sensi SL; ;
    J Alzheimers Dis; 2022; 85(4):1639-1655. PubMed ID: 34958014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
    Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
    Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raman Spectroscopy Techniques for the Investigation and Diagnosis of Alzheimer's Disease.
    Polykretis P; Banchelli M; D'Andrea C; de Angelis M; Matteini P
    Front Biosci (Schol Ed); 2022 Aug; 14(3):22. PubMed ID: 36137977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.